beta
/From Failure to Meet the Clinical Endpoint to U.S. Food and Drug Administration Approval: 15th Antisense Oligonucleotide Therapy Approved Qalsody (Tofersen) for Treatment of SOD1 Mutated Amyotrophic Lateral Sclerosis
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Cited By (0)